Stay updated on Carboplatin Combo in Metastatic Triple-Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Carboplatin Combo in Metastatic Triple-Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin Combo in Metastatic Triple-Negative Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the terminology transition appears above the 403 error page. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:44:41.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T20:58:25.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Removed the 403 Forbidden error page content and the associated HTML structure from the page. The change eliminates the error-state UI and navigation text, aligning the page with the standard study-details layout.
    Difference
    0.5%
    Check dated 2026-09-29T20:48:27.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    A 403 Forbidden error now appears, replacing the study record content and navigation and preventing access to the NCT03121352 study details.
    Difference
    19%
    Check dated 2026-09-22T22:21:41.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The page now displays revision v3.7.0, replacing the previous v3.6.6. This change reflects an update to the page template or content without altering study data or functionality.
    Difference
    0.1%
    Check dated 2026-09-15T21:56:49.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6 replacing v3.6.5, indicating a deployment update; there are no changes to the listed study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-09-01T19:44:15.000Z thumbnail image

Stay in the know with updates to Carboplatin Combo in Metastatic Triple-Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin Combo in Metastatic Triple-Negative Breast Cancer Clinical Trial page.